Pacific Biosciences
PACB
PACB
119 hedge funds and large institutions have $686M invested in Pacific Biosciences in 2015 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 36 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
24% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 29
9% less call options, than puts
Call options by funds: $8.36M | Put options by funds: $9.18M
Holders
119
Holding in Top 10
4
Calls
$8.36M
Puts
$9.18M
Top Buyers
| 1 | +$47.5M | |
| 2 | +$43.1M | |
| 3 | +$28.3M | |
| 4 |
Renaissance Technologies
New York
|
+$20.8M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$10.1M |
Top Sellers
| 1 | -$31.9M | |
| 2 | -$10.5M | |
| 3 | -$9.97M | |
| 4 |
RCM
Raging Capital Management
Rocky Hill,
New Jersey
|
-$5.73M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$2.93M |